These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31833071)

  • 1. The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.
    Guicciardi ME; Trussoni CE; LaRusso NF; Gores GJ
    Hepatology; 2020 Feb; 71(2):741-748. PubMed ID: 31833071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2
    Moncsek A; Al-Suraih MS; Trussoni CE; O'Hara SP; Splinter PL; Zuber C; Patsenker E; Valli PV; Fingas CD; Weber A; Zhu Y; Tchkonia T; Kirkland JL; Gores GJ; Müllhaupt B; LaRusso NF; Mertens JC
    Hepatology; 2018 Jan; 67(1):247-259. PubMed ID: 28802066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.
    Frank AK; Chung BK; De Novales MLL; Engesæter LK; Hoyle HW; Øgaard J; Heslop J; Karlsen TH; Tysoe O; Brevini T; Tchorz JS; Vallier L; Mohorianu I; Sampaziotis F; Melum E
    Dig Dis Sci; 2024 Oct; 69(10):3810-3823. PubMed ID: 39160386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.
    Tabibian JH; O'Hara SP; Splinter PL; Trussoni CE; LaRusso NF
    Hepatology; 2014 Jun; 59(6):2263-75. PubMed ID: 24390753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
    Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
    Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiologic and pathologic experimental models for studying cholangiocytes].
    Lee SO
    Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation.
    Jiang X; Otterdal K; Chung BK; Maucourant C; Rønneberg JD; Zimmer CL; Øgaard J; Boichuk Y; Holm S; Geanon D; Schneditz G; Bergquist A; Björkström NK; Melum E
    Gastroenterology; 2024 Apr; 166(4):667-679. PubMed ID: 37995866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
    Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
    Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
    Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.
    Marzioni M; Saccomanno S; Agostinelli L; Rychlicki C; De Minicis S; Pierantonelli I; Trauner M; Fickert P; Müller T; Shanmukhappa K; Trozzi L; Candelaresi C; Baroni GS; Benedetti A
    J Hepatol; 2013 Apr; 58(4):750-6. PubMed ID: 23207146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.
    Tabibian JH; Trussoni CE; O'Hara SP; Splinter PL; Heimbach JK; LaRusso NF
    Lab Invest; 2014 Oct; 94(10):1126-33. PubMed ID: 25046437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence in the cholangiopathies.
    Bogert PS; O'Hara SP; LaRusso NF
    Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.